Key Insights

Highlights

Treatment Research

2 treatments under study, led by Kp001

Research Leaders

6 sponsors active, led by Boston Children's Hospital

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 3 (1)

Trial Status

Recruiting2
Active Not Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07285005Phase 3Recruiting

A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome

NCT02399527Recruiting

Lymphatic Anomalies Registry for the Assessment of Outcome Data

NCT06642051Not ApplicableActive Not Recruiting

Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery

Showing all 3 trials

Research Network

Common Treatments

  • Kp0011
  • High Intensity Focused Ultrasound1

Active Sponsors

  • Boston Children's Hospital1
  • Lymphatic Malformation Institute1
  • Sonablate1
  • Vascular Care CT, PLLC1
  • Vascular Breakthroughs, LLC1

Top Investigators

Related Conditions

  • Cloves Syndrome3
  • Venous Malformations2
  • Blue Rubber Bleb Nevus Syndrome2
  • Gorhamstout Disease Disappearing Bone Disease1
  • Lymphatic Malformations1

Activity Timeline